Latest Market Challenges News

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

Ryman Healthcare has unveiled a refreshed strategy focused on growing recurring earnings and optimising its portfolio, targeting a $150 million sustainable cash flow improvement and $500 million cash release by FY29. The company plans to resume dividends from FY28, underpinned by a resilient balance sheet and disciplined capital management.

Retail Food Group has refinanced its senior debt with a new $41.2 million facility to back its Enhance & Grow strategy, while updating earnings guidance amid challenging trading conditions.

Credit Corp Group posted a steady first half with 4% revenue growth and flat net profit, setting the stage for a robust second half driven by increased lending and debt buying investments.

DigitalX Limited has increased its Bitcoin exposure to approximately 504 BTC while implementing a significant operational reset that delivered $1 million in annualised cost savings. The company also deployed A$4.9 million into a market-neutral trading strategy to generate sustainable cash flows.

North Stawell Minerals has reported promising diamond drilling results at its Darlington Prospect, reinforcing its status as a key target within the Stawell Mineralised Corridor. The company also secured $900,000 in new funding to support its 2026 exploration plans.

Australis Oil & Gas reported steady production in Q4 2025 despite lower oil prices, completing key transactions that bolster its financial position and development prospects in the Tuscaloosa Marine Shale.

QEM Limited is progressing its strategic review of the Julia Creek Vanadium and Energy Project while advancing key environmental studies and managing capital prudently.

Adheris Health reported a sharp decline in Q2 FY26 revenue but is pushing ahead with leadership changes, cost cuts, and a new digital platform to reshape its future.

Holista Colltech has reported a positive operating cash flow for the December quarter, driven by disciplined cost management and a successful capital raise, despite softer sales and ongoing legal disputes.

Medical Developments International has posted positive operating cashflow for the first half of FY26, driven by robust growth in its flagship product Penthrox across Australia and Europe, alongside progress in paediatric approvals.

Brookside Energy delivered steady production and strong cash flow from its Anadarko Basin assets in the December 2025 quarter, while advancing its Riverbend project and continuing an active share buy-back program.